Results 1 to 10 of about 25,321 (265)

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer’s disease retina [PDF]

Nature Communications
Chlamydia pneumoniae is an intracellular bacterium implicated in Alzheimer’s disease (AD), but its role in retinal pathology and disease progression is unclear.
Bhakta Prasad Gaire, Yosef Koronyo, Jean-Philippe Vit, Alexandre Hutton, Lalita Subedi, Dieu-Trang Fuchs, Natalie Swerdlow, Altan Rentsendorj, Saba Shahin, Daisy Martinon, Edward Robinson, Alexander V. Ljubimov, Julie A. Schneider, Lon S. Schneider, Debra Hawes, Stuart L. Graham, Vivek K. Gupta, Mehdi Mirzaei, Keith L. Black, Jesse G. Meyer, Moshe Arditi, Timothy R. Crother, Maya Koronyo-Hamaoui   +22 more
doaj   +2 more sources

Establishment and Performance Evaluation of Multiplex PCR-Dipstick DNA Chromatography for Mycoplasma pneumoniae and Chlamydia pneumoniae Rapid Detection [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 2023
Background and Objective. Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) infections are becoming increasingly prominent in respiratory infections.
Liuyang Hu, Xiuri Wang, Donglin Cao, Qiuchen Cheng, Qiong Li   +4 more
doaj   +2 more sources

Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infection. [PDF]

PLoS ONE, 2014
Pathogenic Gram-negative bacteria use type III secretion (T3S) to inject effector proteins into the host cell to create appropriate conditions for infection and intracellular replication. Chlamydia spp.
David C Bulir, Daniel A Waltho, Christopher B Stone, Kenneth A Mwawasi, Jordan C Nelson, James B Mahony   +5 more
doaj   +3 more sources

Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: a prospective study Chlamydia pneumoniae e placa aterosclerótica sintomática de carótida: um estudo prospectivo

Arquivos de Neuro-Psiquiatria, 2007
OBJECTIVE: To investigate the possible link between symptomatic carotid atherosclerotic plaque and Chlamydia pneumoniae. BACKGROUND: Recently, several studies have demonstrated that there may be a possible link between Chlamydia pneumonia and carotid ...
Rubens J. Gagliardi, Denise R. Silveira, Roberto A. Caffaro, Vanessa Prado dos Santos, Hélio H. Caiaffa-Filho   +4 more
doaj   +2 more sources

Surge in <i>Chlamydia pneumoniae</i> infections in China: insights from 2022 to 2024. [PDF]

Emerg Microbes Infect
Qin T, Qin XC, Sun Y, Wang W, Xu J.
europepmc   +3 more sources

HSP60, SP110 and TNF-α expression in Chlamydia pneumoniae-positive versus Chlamydia pneumoniae-negative atherosclerotic plaques

Polish Journal of Pathology, 2022
Traditionally recognized risk factors for atherosclerosis are not presented in 50% of patients with ischemic heart disease. Chronic inflammation with low pathogenic agents with slightly, or no signs of inflammation is the mainstay of atherosclerosis and ...
Nemanja Radojevic, Batric Vukcevic, Andrea Jovovic, Filip Vukmirovic   +3 more
doaj   +1 more source

Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

Antibiotics, 2021
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected.
Giancarlo Pérez-Lazo, Wilmer Silva-Caso, Juana del Valle-Mendoza, Adriana Morales-Moreno, José Ballena-López, Fernando Soto-Febres, Johanna Martins-Luna, Hugo Carrillo-Ng, Luís J. del Valle, Sungmin Kym, Miguel Angel Aguilar-Luis, Issac Peña-Tuesta, Carmen Tinco-Valdez, Luis Ricardo Illescas   +13 more
doaj   +1 more source

Identification of Co-Infections by Viral and Bacterial Pathogens in Covid-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

International Journal of Infectious Diseases, 2022
Purpose: The impact of respiratory coinfections in COVID-19 is still not well understood. This study sought to identify the respiratory pathogens causing coinfections in patients with moderate/severe SARS-CoV-2 pneumonia from a hospital in Peru. Also, to
G. Pérez-Lazo, W. Silva-Caso, J. Del Valle-Mendoza, A. Morales-Moreno, M.A. Aguilar-Luis, F. Soto-Febres, H. Carrillo-Ng, L.J. Del Valle, C. Tinco-Valdez, J. Martins-Luna, I. Peña-Tuesta, J. Ballena-López, L.R. Illescas   +12 more
doaj   +1 more source

CHLAMYDIA PNEUMONIAE: THE POTENTIAL CAUSE OF MULTIPLE SCLEROSIS

The Iraqi Journal of Medical Sciences, 2016
Background:Multiple sclerosis is an autoimmune disease, its etiology until know is unknown. Many studies suggested that the environmental risk factors one of them is chlamydia Pneumoniae may play a role in the initiation of the disease.
Alaa H. Khaliel, Ahmed A.H. Abbas
doaj   +6 more sources

Prediction of Chlamydia pneumoniae protein localization in host mitochondria and cytoplasm and possible involvements in lung cancer etiology: a computational approach

Saudi Pharmaceutical Journal, 2017
Collecting evidence suggests that the intercellular infection of Chlamydia pneumoniae in lungs contributes to the etiology of lung cancer. Many proteins of Chlamydia pneumoniae outmanoeuvre the various system of the host.
Aws Alshamsan, Shahanavaj Khan, Ahamad Imran, Ibrahim A. Aljuffali, Khalid Alsaleh   +4 more
doaj   +1 more source